Citadel Advisors - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328900. A total of 4 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$58,000
-84.6%
10,800
-76.0%
0.00%
Q1 2016$377,000
+314.3%
45,000
+291.3%
0.00%
Q4 2015$91,000
-61.4%
11,500
-58.5%
0.00%
Q3 2015$236,000
-23.9%
27,700
+10.4%
0.00%
Q2 2015$310,000
+23.5%
25,100
+19.0%
0.00%
Q1 2015$251,0000.0%21,100
-5.0%
0.00%
Q4 2014$251,000
+2.4%
22,200
-20.4%
0.00%
Q3 2014$245,000
+0.8%
27,900
-16.2%
0.00%
Q2 2014$243,000
+150.5%
33,300
+72.5%
0.00%
Q1 2014$97,000
+61.7%
19,300
+70.8%
0.00%
Q4 2013$60,000
+1100.0%
11,300
+769.2%
0.00%
Q3 2013$5,0001,3000.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2014
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 196,700$1,727,0000.03%
PEAK6 Group LLC 92,400$811,0000.01%
Citadel Advisors 27,900$245,0000.00%
BLAIR WILLIAM & CO/IL 5,000$43,0000.00%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders